| Product Code: ETC9567021 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Therapeutic Vaccines Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Sweden Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Sweden Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Sweden Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Sweden leading to a higher demand for therapeutic vaccines. |
4.2.2 Growing awareness about the benefits of preventive healthcare measures among the Swedish population. |
4.2.3 Government initiatives supporting research and development in the field of therapeutic vaccines. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of therapeutic vaccines leading to a longer time to market. |
4.3.2 High development costs associated with research, clinical trials, and manufacturing of therapeutic vaccines. |
5 Sweden Therapeutic Vaccines Market Trends |
6 Sweden Therapeutic Vaccines Market, By Types |
6.1 Sweden Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Sweden Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Sweden Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Sweden Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Sweden Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Sweden Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Sweden Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Sweden Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Sweden Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Sweden Therapeutic Vaccines Market Export to Major Countries |
7.2 Sweden Therapeutic Vaccines Market Imports from Major Countries |
8 Sweden Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of clinical trials for therapeutic vaccines conducted in Sweden. |
8.2 Investment in research and development by pharmaceutical companies in the therapeutic vaccines sector. |
8.3 Adoption rate of therapeutic vaccines among healthcare providers in Sweden. |
9 Sweden Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Sweden Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Sweden Therapeutic Vaccines Market - Competitive Landscape |
10.1 Sweden Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Sweden Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here